P. Ziccardi

Friend or foe? The tumour microenvironment dilemma in colorectal cancer.

G. Mazzoccoli, A. Lupo, V. Colantuoni, 2017, Biochimica et biophysica acta. Reviews on cancer.

A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability

E. Novellino, A. Lavecchia, A. Lupo, 2017, Scientific Reports.

New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity.

A. Lavecchia, A. Lupo, V. Colantuoni, 2017, European journal of medicinal chemistry.

The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells

G. Mazzoccoli, G. Matarese, V. Colantuoni, 2016, Cell Death and Disease.

Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists

A. Lavecchia, A. Lupo, V. Colantuoni, 2019, Scientific Reports.

The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligands.

E. Novellino, A. Lavecchia, A. Lupo, 2016, Biochemical pharmacology.

Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer

M. Fassan, G. Mazzoccoli, A. Piepoli, 2016, Cell Death and Disease.

Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists

A. Lavecchia, A. Lupo, V. Colantuoni, 2019, Scientific Reports.